News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
260
Sources here
18
Companies here
5
Search results Stored financial headlines

Active search

260 matching headlines

Ticker or company: NSMMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TransMedics Grants Stock Awards to 9 Employees Joining Company

TransMedics (Nasdaq: TMDX) announced it granted stock options for 18,762 shares and 12,414 restricted stock units to nine new employees on July 29, 2026. These awards serve as material inducements for employment under its Inducement Plan and Nasdaq Listing Rule 5635(c)(4). The stock options …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Allison Announces Second Quarter 2026 Results

Net Sales of $1,566 million, up 92% year over year, including the addition of the Allison Off-Highway business unit acquired on January 1, 2026 Record quarterly net sales of $860 million for the Allison Transmission business unit Net Income of $181 million, 12% of …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TMDX Maintained by Needham -- Price Target Lowered to $106.00

Needham has maintained a 'Buy' rating on TransMedics Group (TMDX) but lowered its price target from $142.00 to $106.00, reflecting a 25.35% decrease and a more cautious outlook. Despite this, GuruFocus indicates TMDX is 55.4% undervalued, with strong growth potential but challenges in profitability …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TransMedics Group Jumps 7.5% After UBS Initiates at Neutral

TransMedics Group's stock surged 7.5% after UBS initiated coverage with a Neutral rating and an $80 price target. Despite the cautious rating, the market viewed the initiation as validation, pushing the stock to $82.22, above the analyst's target. Investors will monitor future analyst coverage …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Militia Capital Management LLC Purchases Shares of 21,000 TransMedics Group, Inc. $TMDX

Militia Capital Management LLC recently acquired 21,000 shares of TransMedics Group, Inc. worth approximately $2.09 million. The company's stock, trading under NASDAQ:TMDX, currently holds a consensus "Hold" rating from analysts with an average price target of $129.55, despite missing recent quarterly earnings estimates. Institutional …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(TMDX) Risk Channels and Responsive Allocation

This article provides an AI-driven analysis of Transmedics Group Inc. (NASDAQ: TMDX), highlighting a potential shift in near-term positive sentiment and a mid-channel oscillation pattern. It identifies an exceptional short setup with a significant risk-reward ratio and outlines three distinct trading strategies: a position …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Janus Henderson Group PLC Purchases 121,129 Shares of Allison Transmission Holdings, Inc. $ALSN

Janus Henderson Group PLC increased its stake in Allison Transmission Holdings, Inc. (NYSE:ALSN) by 32.7% in the first quarter, purchasing an additional 121,129 shares to hold a total of 491,105 shares valued at $57.5 million. Other institutional investors also adjusted their positions in the …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Allison Transmission (ALSN) To Report Earnings Tomorrow: Here Is What To Expect

Allison Transmission (ALSN) is set to report earnings, with analysts expecting an 86.7% year-on-year revenue growth. Despite the positive outlook for this quarter, the company has historically missed Wall Street's revenue estimates multiple times. Peers in the heavy transportation equipment segment, like Wabash and …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TransMedics Group, Inc. Revenue Breakdown – MIL:1TMDX

TransMedics Group, Inc. (1TMDX) generated 515.53 million EUR in revenue last year. The Liver Organ Care System segment was the top performer, contributing 392.10 million EUR, an increase from the previous year. The United States was the largest regional contributor, accounting for 497.82 million …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Preview: Insmed to Report Financial Results Pre-market on August 06

Insmed (INSM) is scheduled to release its financial results on August 06 before market open. Analysts expect the company to report an EPS of -$0.36 and revenue of $69.75 million. This will be a key event for investors to assess the company's performance and …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to earnings forward of TransMedics Group, Inc. – NASDAQ:TMDX

This page provides financial data for TransMedics Group, Inc. (NASDAQ: TMDX), specifically focusing on its forward price-to-earnings ratio. It highlights that the information is "Made by humans" and sources its market and reference data from ICE Data Services and FactSet, respectively. The content appears …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insmed Slips as Traders Appear to Await Earnings Despite Recent Positive Pipeline Updates

Insmed (INSM) shares are experiencing a decline as traders seem to be anticipating upcoming earnings, despite recent positive news regarding the company's pipeline. The stock has been trading with increased volume and has seen significant short interest, with a high short float and days …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vanguard Portfolio Management (ALSN) discloses 4.82% beneficial stake in Allison Transmission

Vanguard Portfolio Management LLC has disclosed an amended beneficial ownership stake of 4.82% in Allison Transmission Holdings Inc. as of June 30, 2026. This represents 4,000,079 shares of common stock, with Vanguard holding sole voting power over 14,535 shares and sole dispositive power over …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insmed Stock And 2 Healthcare Names To Watch As DOJ Uncertainty Builds

This article examines three healthcare stocks that are particularly sensitive to regulatory shifts, especially concerning the Department of Justice's policies and corporate taxation. With the nomination of a new U.S. Attorney General facing delays and increased scrutiny on DOJ settlements, companies like AnaptysBio, Insmed, …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Allison Transmission Holdings, Inc. $ALSN Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Allison Transmission Holdings, Inc. by 38.2% in the first quarter, now holding 38,700 shares valued at approximately $4.53 million. This increase reflects broader institutional interest, with such investors owning 96.9% of the …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Insmed (INSM) is predicted to report a year-over-year increase in earnings and higher revenues for Q2 2026. The company is expected to post a quarterly loss of $0.69 per share with revenues of $389.72 million, surpassing previous estimates. A positive Earnings ESP of +22.32% …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insmed Inc (INSM) Institutional Confidence

Insmed Inc (INSM) has a strong institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. Institutional ownership has increased by 0.02% quarter-over-quarter, with Stanley Druckenmiller being the largest holder despite a slight decrease in his personal holdings. Several …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TMDX|Transmedics Group Inc|Price:78.040|Chg%:+1.750

This article provides a comprehensive stock analysis of Transmedics Group Inc (TMDX) by TradingKey, assigning it a positive score for fundamental health and growth potential while noting its fair valuation. It highlights the company's strengths in organ transplant technology, high institutional ownership, and a …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insmed Inc (INSM) Financial Health: Profitability & Balance Sheet Analysis

Insmed Inc (INSM) has a strong financial health score of 8.56, ranking 39th in the Biotechnology & Medical Research industry, indicating stable financial status and high operating efficiency. The company reported a significant quarterly revenue increase of 229.62% year-over-year, reaching $305.96 million, with net …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lazard Asset Management LLC Has $29.81 Million Stock Position in Allison Transmission Holdings, Inc. $ALSN

Lazard Asset Management LLC significantly increased its stake in Allison Transmission Holdings, Inc. (NYSE:ALSN) by 41.1% in the first quarter, now holding 254,624 shares valued at $29.81 million. Other institutional investors also adjusted their positions, and insider activity shows CFO Scott A. Mell sold …

ALSN main company
Sharemaestro market context Trend signal started 52 weeks +42.1% ALSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

INSM|Insmed Inc|Price:104.080|Chg%:-0.650

Insmed Inc (INSM) is currently trading at $104.08, down 0.62%. The company's fundamentals are strong with high growth potential, and it is considered fairly valued. Analysts have a "Buy" rating on the stock, with a target price of $196.96, indicating an 84.22% upside potential …

INSM main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% INSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TransMedics to present at Canaccord Genuity Growth Conference on Aug 11, showcasing organ transplant tech. TMDX $76.26 +$1.98 +2.67%

TransMedics Group, a leader in organ transplant technology, announced it will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026. The company specializes in portable organ preservation and assessment devices that improve transplant outcomes for heart, lung, and …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TMDX Initiated Coverage by UBS -- Price Target Set at $80.00

UBS has initiated coverage on TransMedics Group (TMDX) with a Neutral rating and a price target of $80.00. While GuruFocus identifies TMDX as 56.0% undervalued with strong growth potential, the mixed signals from analysts and insider selling suggest caution for investors. The company, a …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

ANDOVER, Mass., July 28, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in the Canaccord Genuity 46th …

TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -26.1% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TransMedics' Aug. 11 Boston fireside chat will be webcast

TransMedics (Nasdaq: TMDX) announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026. The management team will present at 2:00 p.m. ET, and a live and archived webcast of the fireside chat will be available on the …

TMDX main company TMDX main company
Sharemaestro market context Price below Trend Line 52 weeks -32.1% · Next-week setup positive 56.0% TMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context